Historical salary details - Mr. Matthew K. Fust, Independent Director, Atara Biotherapeutics Inc
Mr. Matthew K. Fust is the Independent Director of Atara Biotherapeutics Inc. They also hold 3 other positions in Neumora Therapeutics Inc., Ultragenyx Pharmaceutical Inc. and Crinetics Pharmaceuticals Inc.
Mr. Matthew K. Fust
Independent Director
-
Gross Remuneration
-
Current Company
Atara Biotherapeutics Inc
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Atara Biotherapeutics Inc | Independent Director | - | - |
| 2024 | Neumora Therapeutics Inc. | Independent Director | - | - |
| 2024 | Ultragenyx Pharmaceutical Inc. | Independent Director | - | - |
| 2024 | Crinetics Pharmaceuticals Inc | Independent Director | - | - |
| 2023 | Neumora Therapeutics Inc. | Independent Director | 485.5 K | 1113.8 % |
| 2023 | Ultragenyx Pharmaceutical Inc. | Independent Director | 479.9 K | 0.4 % |
| 2023 | Crinetics Pharmaceuticals Inc | Independent Director | 348.6 K | 18.8 % |
| 2022 | Ultragenyx Pharmaceutical Inc. | Independent Director | 478.2 K | 0.6 % |
| 2022 | Atara Biotherapeutics Inc | Independent Director | 370.3 K | -0.8 % |
| 2022 | Crinetics Pharmaceuticals Inc | Independent Director | 293.4 K | -5.0 % |
| 2022 | Neumora Therapeutics Inc. | Independent Director | 40 K | - |
| 2021 | Ultragenyx Pharmaceutical Inc. | Independent Director | 475.1 K | 7.1 % |
| 2021 | Atara Biotherapeutics Inc | Independent Director | 373.5 K | 16.3 % |
| 2021 | Crinetics Pharmaceuticals Inc | Independent Director | 308.8 K | 23.4 % |
| 2020 | Ultragenyx Pharmaceutical Inc. | Independent Director | 443.6 K | 6.1 % |
| 2020 | Atara Biotherapeutics Inc | Independent Director | 321.0 K | 1.1 % |
| 2020 | Crinetics Pharmaceuticals Inc | Independent Director | 250.3 K | 3.5 % |
| 2020 | Macrogenics Inc | - | 25.3 K | -86.6 % |
| 2020 | Macrogenics Inc | Independent Director | - | - |
| 2019 | Ultragenyx Pharmaceutical Inc. | Independent Director | 417.9 K | -24.1 % |
| 2019 | Atara Biotherapeutics Inc | Independent Director | 317.5 K | 21.3 % |
| 2019 | Crinetics Pharmaceuticals Inc | Independent Director | 241.8 K | 192.8 % |
| 2019 | Macrogenics Inc | Independent Director | 188.7 K | -7.6 % |
| 2018 | Ultragenyx Pharmaceutical Inc. | Independent Director | 550.7 K | 59.1 % |
| 2018 | Atara Biotherapeutics Inc | Independent Director | 261.8 K | -22.5 % |
| 2018 | Macrogenics Inc | Independent Director | 204.3 K | 12.2 % |
| 2018 | Crinetics Pharmaceuticals Inc | Independent Director | 82.6 K | - |
| 2017 | Ultragenyx Pharmaceutical Inc. | Independent Director | 346.1 K | 4.1 % |
| 2017 | Atara Biotherapeutics Inc | Independent Director | 337.9 K | 66.0 % |
| 2017 | Macrogenics Inc | Independent Director | 182.2 K | 7.9 % |
| 2017 | Crinetics Pharmaceuticals Inc | Independent Director | - | - |
| 2016 | Ultragenyx Pharmaceutical Inc. | Independent Director | 332.6 K | -28.7 % |
| 2016 | Atara Biotherapeutics Inc | Independent Director | 203.6 K | -17.6 % |
| 2016 | Macrogenics Inc | Independent Director | 168.8 K | -31.1 % |
| 2015 | Ultragenyx Pharmaceutical Inc. | Independent Director | 466.2 K | 0.9 % |
| 2015 | Atara Biotherapeutics Inc | Independent Director | 247.1 K | -1.3 % |
| 2015 | Macrogenics Inc | Independent Director | 245.0 K | -44.1 % |
| 2014 | Ultragenyx Pharmaceutical Inc. | Independent Director | 462.1 K | - |
| 2014 | Macrogenics Inc | Independent Director | 438.0 K | - |
| 2014 | Atara Biotherapeutics Inc | Independent Director | 250.3 K | - |
| 2013 | Macrogenics Inc | Independent Director | - | - |
| 2013 | Ultragenyx Pharmaceutical Inc. | Independent Director | - | - |
| 2013 | Atara Biotherapeutics Inc | Independent Director | - | - |